Cepheid wins FDA clearance for Xpert Respiratory Panel test
DHR•Cepheid received FDA clearance for its Xpert Respiratory Panel multiplex PCR test, which detects 13 viral and bacterial pathogens from one nasopharyngeal swab. U.S. shipments are set to start in the coming weeks.
1. Test receives clearance
Cepheid, a Danaher unit, received FDA clearance for its Xpert Respiratory Panel multiplex PCR test for suspected respiratory tract infections. The test detects 13 common viral and bacterial pathogens from a single nasopharyngeal swab on existing GeneXpert systems, with U.S. shipments set to start in the coming weeks.
